In NEJM: Dose Escalation Best Approach for Sickle Cell Med in Africa

Post Date: June 25, 2020 | Publish Date: June 25, 2020


Russell Ware, MD, PhD

“The study shows clearly that the optimized dosing strategy for hydroxyurea, though it requires more effort than a fixed-dose treatment regimen, results in far better outcomes for children with sickle cell anemia,”

— Russell Ware, MD, PhD

Publication Information

Original Title:Hydroxyurea Dose Escalation for Sickle Cell Anemia in Sub-Saharan Africa
Published in:New England Journal of Medicine
Publish date:June 25, 2020

Read the Study